K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
<p><strong>Background</strong></p> Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Mya...
Prif Awduron: | Win, AA, Imwong, M, Kyaw, MP, Woodrow, CJ, Chotivanich, K, Hanboonkunupakarn, B, Pukrittayakamee, S |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
BioMed Central
2016
|
Eitemau Tebyg
-
Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness.
gan: Preechapornkul, P, et al.
Cyhoeddwyd: (2009) -
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
gan: Price, R, et al.
Cyhoeddwyd: (2004) -
<it>Pfmdr1 </it>copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia
gan: Wongsrichanalai Chansuda, et al.
Cyhoeddwyd: (2009-01-01) -
Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
gan: Mayxay, M, et al.
Cyhoeddwyd: (2001) -
Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola
gan: Denise Duarte, et al.
Cyhoeddwyd: (2025-01-01)